Remote sampling growth Trajan’s focus on microsampling technologies and VAMS based Mitra device supports decentralized healthcare and remote patient monitoring, presenting an opportunity to upsell to clinical research organizations and healthcare providers expanding remote testing capabilities.

Strategic distribution Recent distributor partnerships and Canadian/Polish market coverage indicate a channel-ready approach; leverage these relationships to promote Mitra and Harpera solutions in new regions and expand through regional distributors and CROs.

Product expansion Launch of HDExaminer PRO v1.0 at ASMS 2026 signals ongoing product development; position for customers needing scalable, automated microsampling workflows and data management enhancements to replace legacy workflows.

Clinical research demand Validated across thousands of publications and used in therapeutic drug monitoring and personalized medicine; target pharmaceutical companies, contract research organizations, and academic labs seeking reliable, easy-to-implement remote sampling to speed studies.

Financial and leadership shifts Recent CFO appointment and joint company secretary changes suggest an evolving governance and growth phase; proactively engage finance and ops stakeholders in budgets for trials, regulatory support, and expanded training for customers adopting Mitra and Harpera technologies.